Massive Markups on IV Saline Bags Reveal Opacity in Hospital Billing
Massive Markups on IV Saline Bags Reveal Opacity in Hospital Billing The passage documents extreme price inflation (up to 1,000‑fold) for a basic medical supply and highlights secretive pricing practices among manufacturers, distributors, and insurers. While it names major pharma firms (Baxter, Hospira) and suggests systemic overcharging, it lacks specific transaction details, dates, or direct links to high‑level officials, limiting immediate investigative action but offering a solid lead into healthcare pricing abuse. Key insights: IV saline bags cost manufacturers 44¢–$1, yet patient bills show markups of 100‑1,000×.; Charges vary dramatically based on insurance status (private, Medicare/Medicaid, uninsured).; Manufacturers (Baxter, Hospira) claim price data is private despite required federal reporting.
Summary
Massive Markups on IV Saline Bags Reveal Opacity in Hospital Billing The passage documents extreme price inflation (up to 1,000‑fold) for a basic medical supply and highlights secretive pricing practices among manufacturers, distributors, and insurers. While it names major pharma firms (Baxter, Hospira) and suggests systemic overcharging, it lacks specific transaction details, dates, or direct links to high‑level officials, limiting immediate investigative action but offering a solid lead into healthcare pricing abuse. Key insights: IV saline bags cost manufacturers 44¢–$1, yet patient bills show markups of 100‑1,000×.; Charges vary dramatically based on insurance status (private, Medicare/Medicaid, uninsured).; Manufacturers (Baxter, Hospira) claim price data is private despite required federal reporting.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.